Our INTEGRIS-PSC trial is evaluating if PLN-74809 may slow disease progression by targeting the fibrosis process in… https://t.co/KeO019u6mg
A Friday afternoon brought together 70 Team Pliant members and #Chopped champion @BrookeSiem to make amazing paella… https://t.co/mBrFCx98IG
We are looking forward to participating in the #Respiratory and Infectious Disease panel discussion today, March 1s… https://t.co/p5240Ue86p
Team Pliant joins all the #raredisease advocates from around the world in recognizing #RareDiseaseDay2021 this Sund… https://t.co/1jKDHV3bWs
Our innovative approach is focused on fighting #fibrosis. In Part 1 of a 3-part video series, learn the role of the… https://t.co/V37UP3A8Or
Our INTEGRIS-IPF #clinicaltrial is evaluating our investigational medicine, PLN-74809, in people with #IPF. PLN-748… https://t.co/9D6pY0mjNq
Patient #safety while participating in a #clinical trial is our highest priority as we continue to enroll participa… https://t.co/Q1jIaPdxYN
Are you interested in joining a clinical trial for #PSC or #IPF? Like to learn more about what a #clinicaltrial is… https://t.co/0vv9KPZ9qz
Pliant is breaking new ground in developing #fibrosis treatments. Our leading teams of fibrosis and drug developmen… https://t.co/BwVw5KBNd7
Hans Hull, J.D, Pliant’s Chief Business Officer is this week’s spotlight. Hans is an accomplished biotechnology exe… https://t.co/ZMdtgq9ypF
Similar Businesses
